Cantor Fitzgerald Weighs in on Actinium Pharmaceuticals, Inc.’s FY2024 Earnings (NYSEAMERICAN:ATNM)
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Cantor Fitzgerald raised their FY2024 earnings estimates for Actinium Pharmaceuticals in a report released on Monday, April 1st. Cantor Fitzgerald analyst K. Kluska now expects that the biotechnology company will earn ($1.84) per share for the year, up from their previous estimate of ($2.14). Cantor Fitzgerald currently […]
More Stories
Critical Contrast: Senmiao Technology (NASDAQ:AIHS) versus Avis Budget Group (NASDAQ:CAR)
Senmiao Technology (NASDAQ:AIHS – Get Free Report) and Avis Budget Group (NASDAQ:CAR – Get Free Report) are both computer and...
IRS Sending $2.4 Billion in Payments to 1 Million Taxpayers Who Missed Out on Stimulus Checks
By Tom Ozimek The Internal Revenue Service (IRS) has announced that around $2.4 billion worth of automatic payments will be...
More Than 10,000 Pounds of Meat Products Recalled in 4 US States
By Naveen Athrappully More than 10,000 pounds of pork and beef items are being pulled out from U.S. stores by...
Financial Review: Alarm.com (NASDAQ:ALRM) versus Alarum Technologies (NASDAQ:ALAR)
Alarm.com (NASDAQ:ALRM – Get Free Report) and Alarum Technologies (NASDAQ:ALAR – Get Free Report) are both industrial products companies, but...
Trump Says US Will Take Back Control of Panama Canal If US Interests Threatened
By Melanie Sun President-elect Donald Trump has said he will take back control of the Panama Canal from the nation’s...
Comparing Bath & Body Works (BBWI) & Its Competitors
Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 publicly-traded companies in the “Retail stores, not...